Table 2.
Detection capacities of different genetic testing methodologies
| Genetic testing methodology | Number of genes or genetic regions analyzed | Methylation | Noncoding variants | SNV | Small Indels | Balanced structural variants | Unbalanced structural variants | Possibility of secondary or incidental finding/s | Genetic mosaicism detection |
|---|---|---|---|---|---|---|---|---|---|
| Sanger sequencing | 1 gene | No | Yes | Yes | < 10 bp | No | No | None | Limited |
| MLPA | < 50 genetic regions | No | Yes | No | No | No | 1 kb–15 Mb | Low | No |
| Karyotype | All | No | Yes | No | No | Yes | > 5 Mb | 1–3% | No |
| FISH | 1 | No | Yes | No | No | Yes | > 100 kb | None | Yes |
| Chromosomal microarray | genome-wide | No | Yes | No | No | No | > 50 kb | 1–3% | No |
| Methylation array | Range of 1 to genome-wide | Yes | Yes | No | No | No | No | Low | Limited |
| Targeted NGS panels | 5–250 | No | No | Yes | < 100 bp | No | Variablea | Low | Yes |
| Broad NGS panels | 350–500 | No | No | Yes | < 100 bp | No | Variablea | Variablea | Yes |
| Exome sequencingb | genome-wide | No | No | Yes | < 100 bp | No | Variablea | ∼3% | Yes |
| Genome sequencingb | genome-wide | No | Yes | Yes | Yes | No | Variablea | ∼3% | Yes |
FISH, Fluorescent in situ hybridization; MLPA, Multiplex ligation probe–dependent amplification; NGS, next-generation sequencing; SNV, Single nucleotide variants.
Depending on laboratories and often require confirmation with FISH, chromosomal microarray or MLPA.
Short-read sequencing.